Skip to main content
logo
Ircon International Limited (NSE:IRCON)
India flag India · Delayed Price · Currency is INR
167.71
-4.07 (-2.37%)
Aug 7, 2025, 3:30 PM IST

CTI BioPharma Revenue

In the fiscal year ending March 31, 2025, Ircon International had annual revenue of 107.60B INR, down -12.74%. Ircon International had revenue of 34.12B in the quarter ending March 31, 2025, a decrease of -8.83%.

Revenue
107.60B
Revenue Growth
-12.74%
P/S Ratio
1.54
Revenue / Employee
118.32M
Employees
867
Market Cap
157.73B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025107.60B-15.71B-12.74%
Mar 31, 2024123.31B19.63B18.93%
Mar 31, 2023103.68B29.88B40.49%
Mar 31, 202273.80B20.30B37.94%
Mar 31, 202153.50B-412.80M-0.77%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Hindustan Aeronautics309.81B
Adani Ports and Special Economic Zone326.45B
InterGlobe Aviation817.29B
Mazagon Dock Shipbuilders117.00B
Siemens222.24B
CG Power and Industrial Solutions105.59B
Polycab India236.16B
GMR Airports112.17B
Revenue Rankings

Ircon International News

More News